STANDARD BIOTOOLS INC LAB 5.25 12.01.24
NOTE 5.250%12/0 · US DOMESTIC · CUSIP 34385PAF5
6
institutional holders
+0 vs Q3 2022
$57.8mprincipal reported held*
$48.8mreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $2.4m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($2.4m this quarter). Holder counts are more reliable.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
Biggest buyers
| None |
Biggest sellers
| Verition Fund Management LLC | Reduced | -2.8m |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Indaba Capital Management, L.P. 5.63% of their portfolio | 32.7m $29.1m | Unchanged |
| DeepCurrents Investment Group LLC 0.36% of their portfolio | 9.5m $8.4m | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 7.8m $6.8m | Unchanged |
| SILVERBACK ASSET MANAGEMENT LLC 0.73% of their portfolio | 5.0m $4.5m | Unchanged |
| Verition Fund Management LLC 0.05% of their portfolio | 2.8m $2.4m | Reduced -2.8m |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |